ArticleFrontiers in cardiovascular medicine2026
Atrial volumetrics and recurrence after catheter ablation for atrial fibrillation.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: While left atrial (LA) volume enlargement is a well-known predictor of recurrence after catheter ablation for atrial fibrillation (AF), the association between the recurrence and other atrial volumetrics remains uncertain. This study aimed to assess the association between various atrial volumetrics and the 12-month recurrence of AF after catheter ablation (AFCA). Methods: Patients with a history of AFCA who underwent pre-procedural cardiac computed tomography were retrospectively included. Atrial volumes were measured using artificial intelligence-based segmentation software (AutoSeg-H). Atrial volumetrics included total LA, LA body, LA appendage (LAA), total right atrium (RA), RA body, and RA appendage (RAA) volumes. AF recurrence was defined as any documented atrial arrhythmia (AA) within 12 months following AFCA. All volumetrics were dichotomized using cutoffs that optimally predicted 12-month AA recurrence on the receiver operating characteristic curve. Cox regression models were used to estimate adjusted hazard ratios (aHRs) of the dichotomized volumetrics. Results: Among 199 included patients, 45 (22.6%) underwent AA recurrence within 12 months. All atrial volumetrics were significantly higher in the recurrence group than in the non-recurrence group. Optimal cutoffs used for dichotomizing volumetrics were: total LA ≥129.1, LA body ≥112.0, LAA ≥15.3, total RA ≥123.0, RA body ≥82.1, and RAA ≥13.2 (unit: mL). All dichotomized volumetrics, except RAA ≥ 13.2, were significantly associated with recurrence. LAA volume ≥15.3 [aHR 1.97; 95% confidence interval (CI), 1.04-3.74; Conclusions: Most dichotomized atrial volumetrics were associated with 12-month AA recurrence after AFCA. In particular, LAA ≥15.3 mL and RA body ≥82.1 mL were independently associated with recurrence, suggesting that structural remodeling in these regions may contribute to post-ablation AA recurrence.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.